2021/2013(INI)

A Pharmaceutical Strategy for Europe

Basic information

2021/2013(INI)

INI - Own-initiative procedure

Subject

4.20.04 Pharmaceutical products and industry

Status

Procedure completed

Key players

Key events

Date Event Reference Summary
11/03/2021 Committee referral announced in Parliament
11/03/2021 Referral to associated committees announced in Parliament
12/10/2021 Vote in committee
08/11/2021 Committee report tabled for plenary A9-0317/2021
22/11/2021 Debate in Parliament
23/11/2021 Results of vote in Parliament
24/11/2021 Decision by Parliament T9-0470/2021

Technical information

Procedure Information
Procedure reference 2021/2013(INI)
Procedure type INI - Own-initiative procedure
Nature of procedure Initiative
Legal basis Rules of Procedure EP 57_o Rules of Procedure EP 55
Other legal basis Rules of Procedure EP 165
Stage reached in procedure Procedure completed
Committee dossier ENVI/9/05419

Documentation gateway

  • Document type Committee Reference Date Summary
    Committee draft report PE681.109 03/05/2021
    Amendments tabled in committee PE692.747 02/06/2021
    Amendments tabled in committee PE693.696 03/06/2021
    Amendments tabled in committee PE693.845 10/06/2021
    Committee opinion JURI PE692.709 14/07/2021
    Committee opinion ITRE PE689.816 07/10/2021
    Committee report tabled for plenary, single reading A9-0317/2021 08/11/2021
    Text adopted by Parliament, single reading T9-0470/2021 24/11/2021
  • Document type Reference Date Summary
    Commission response to text adopted in plenary SP(2022)49 18/03/2022

Transparency

Meetings with interest representatives published in line with the Rules of Procedure

  • Name Role Committee Date Interest representatives
    MONTSERRAT Dolors Rapporteur ENVI 19/11/2021 ASOCIACIÓN ESPAÑOLA DE MEDICAMENTOS BIOSIMILARES
    MONTSERRAT Dolors Rapporteur ENVI 03/11/2020 ASOCIACIÓN NACIONAL EMPRESARIAL DE LA INDUSTRIA FARMACÉUTICA